Di Nicola, M.; Pepe, M.; Milintenda, M.; Massetti, M.; Moccia, L.; Panaccione, I.; Sani, G.
Patient Life Engagement and Metabolic Profile Improve After Switching from First-/Second-Generation Antipsychotics to Brexpiprazole: A Real-World Study in Patients with Schizophrenia. J. Pers. Med. 2025, 15, 502.
https://doi.org/10.3390/jpm15110502
AMA Style
Di Nicola M, Pepe M, Milintenda M, Massetti M, Moccia L, Panaccione I, Sani G.
Patient Life Engagement and Metabolic Profile Improve After Switching from First-/Second-Generation Antipsychotics to Brexpiprazole: A Real-World Study in Patients with Schizophrenia. Journal of Personalized Medicine. 2025; 15(11):502.
https://doi.org/10.3390/jpm15110502
Chicago/Turabian Style
Di Nicola, Marco, Maria Pepe, Miriam Milintenda, Marco Massetti, Lorenzo Moccia, Isabella Panaccione, and Gabriele Sani.
2025. "Patient Life Engagement and Metabolic Profile Improve After Switching from First-/Second-Generation Antipsychotics to Brexpiprazole: A Real-World Study in Patients with Schizophrenia" Journal of Personalized Medicine 15, no. 11: 502.
https://doi.org/10.3390/jpm15110502
APA Style
Di Nicola, M., Pepe, M., Milintenda, M., Massetti, M., Moccia, L., Panaccione, I., & Sani, G.
(2025). Patient Life Engagement and Metabolic Profile Improve After Switching from First-/Second-Generation Antipsychotics to Brexpiprazole: A Real-World Study in Patients with Schizophrenia. Journal of Personalized Medicine, 15(11), 502.
https://doi.org/10.3390/jpm15110502